| UniProt ID | CNO6L_HUMAN | |
|---|---|---|
| UniProt AC | Q96LI5 | |
| Protein Name | CCR4-NOT transcription complex subunit 6-like | |
| Gene Name | CNOT6L | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 555 | |
| Subcellular Localization | Cytoplasm. Nucleus. | |
| Protein Description | Has 3'-5' poly(A) exoribonuclease activity for synthetic poly(A) RNA substrate. Catalytic component of the CCR4-NOT complex which is one of the major cellular mRNA deadenylases and is linked to various cellular processes including bulk mRNA degradation, miRNA-mediated repression, translational repression during translational initiation and general transcription regulation. Additional complex functions may be a consequence of its influence on mRNA expression. May be involved in the deadenylation-dependent degradation of mRNAs through the 3'-UTR AU-rich element-mediated mechanism. Involved in deadenylation-dependent degradation of CDKN1B mRNA. Its mRNA deadenylase activity can be inhibited by TOB1. Mediates cell proliferation and cell survival and prevents cellular senescence.. | |
| Protein Sequence | MRLIGMPKEKYDPPDPRRIYTIMSAEEVANGKKSHWAELEISGRVRSLSTSLWSLTHLTALHLNDNYLSRIPPDIAKLHNLVYLDLSSNKLRSLPAELGNMVSLRELLLNNNLLRVLPYELGRLFQLQTLGLKGNPLSQDILNLYQDPDGTRKLLNFMLDNLAVHPEQLPPRPWITLKERDQILPSASFTVMCYNVLCDKYATRQLYGYCPSWALNWEYRKKGIMEEIVNCDADIISLQEVETEQYFTLFLPALKERGYDGFFSPKSRAKIMSEQERKHVDGCAIFFKTEKFTLVQKHTVEFNQVAMANSDGSEAMLNRVMTKDNIGVAVVLEVHKELFGAGMKPIHAADKQLLIVANAHMHWDPEYSDVKLIQTMMFVSEVKNILEKASSRPGSPTADPNSIPLVLCADLNSLPDSGVVEYLSNGGVADNHKDFKELRYNECLMNFSCNGKNGSSEGRITHGFQLKSAYENNLMPYTNYTFDFKGVIDYIFYSKTHMNVLGVLGPLDPQWLVENNITGCPHPHIPSDHFSLLTQLELHPPLLPLVNGVHLPNRR | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 11 | Phosphorylation | IGMPKEKYDPPDPRR CCCCHHHCCCCCHHH | 34.47 | 18083107 | |
| 24 | Phosphorylation | RRIYTIMSAEEVANG HHEEEEEEHHHHHCC | 28.78 | 24719451 | |
| 90 | Acetylation | YLDLSSNKLRSLPAE EEECCCCCHHCCCHH | 47.42 | 25953088 | |
| 90 | Ubiquitination | YLDLSSNKLRSLPAE EEECCCCCHHCCCHH | 47.42 | - | |
| 133 | Ubiquitination | QLQTLGLKGNPLSQD HHHHCCCCCCCCCHH | 55.64 | - | |
| 186 | Phosphorylation | ERDQILPSASFTVMC HCCCCCCCCCEEEEH | 32.85 | 24043423 | |
| 188 | Phosphorylation | DQILPSASFTVMCYN CCCCCCCCEEEEHHH | 26.28 | 24043423 | |
| 190 | Phosphorylation | ILPSASFTVMCYNVL CCCCCCEEEEHHHHH | 12.58 | 24043423 | |
| 201 | Phosphorylation | YNVLCDKYATRQLYG HHHHHHHHHHHHHHC | 10.43 | 24043423 | |
| 203 | Phosphorylation | VLCDKYATRQLYGYC HHHHHHHHHHHHCCC | 18.83 | 24043423 | |
| 212 | Phosphorylation | QLYGYCPSWALNWEY HHHCCCHHHHHCHHH | 22.78 | - | |
| 259 | Phosphorylation | PALKERGYDGFFSPK HHHHHCCCCCCCCHH | 21.08 | 18083107 | |
| 264 | Phosphorylation | RGYDGFFSPKSRAKI CCCCCCCCHHHHHHH | 29.20 | 24719451 | |
| 266 | Ubiquitination | YDGFFSPKSRAKIMS CCCCCCHHHHHHHCC | 51.91 | - | |
| 270 | Ubiquitination | FSPKSRAKIMSEQER CCHHHHHHHCCHHHH | 37.52 | - | |
| 273 | Phosphorylation | KSRAKIMSEQERKHV HHHHHHCCHHHHHCC | 39.33 | 29457462 | |
| 278 | Ubiquitination | IMSEQERKHVDGCAI HCCHHHHHCCCCEEE | 47.42 | - | |
| 289 | Phosphorylation | GCAIFFKTEKFTLVQ CEEEEEECCEEEEEE | 38.97 | - | |
| 291 | Ubiquitination | AIFFKTEKFTLVQKH EEEEECCEEEEEEEE | 49.21 | - | |
| 322 | Phosphorylation | AMLNRVMTKDNIGVA HHHHHHCCCCCCEEE | 32.18 | 22210691 | |
| 344 | Sumoylation | ELFGAGMKPIHAADK HHHCCCCCCCCCCCC | 39.64 | - | |
| 344 | Sumoylation | ELFGAGMKPIHAADK HHHCCCCCCCCCCCC | 39.64 | - | |
| 380 | Phosphorylation | IQTMMFVSEVKNILE HHHHHHHHHHHHHHH | 25.96 | 25404012 | |
| 388 | Ubiquitination | EVKNILEKASSRPGS HHHHHHHHHHCCCCC | 50.56 | - | |
| 390 | Phosphorylation | KNILEKASSRPGSPT HHHHHHHHCCCCCCC | 37.64 | 27080861 | |
| 391 | Phosphorylation | NILEKASSRPGSPTA HHHHHHHCCCCCCCC | 47.56 | 27080861 | |
| 395 | Phosphorylation | KASSRPGSPTADPNS HHHCCCCCCCCCCCC | 23.04 | 27080861 | |
| 397 | Phosphorylation | SSRPGSPTADPNSIP HCCCCCCCCCCCCCC | 45.44 | 24247654 | |
| 402 | Phosphorylation | SPTADPNSIPLVLCA CCCCCCCCCCEEEEE | 30.85 | 27080861 | |
| 452 | Ubiquitination | MNFSCNGKNGSSEGR EEEEECCCCCCCCCC | 44.11 | - | |
| 468 | O-linked_Glycosylation | THGFQLKSAYENNLM CCCEECCCHHHCCCC | 44.68 | 29351928 | |
| 468 | Phosphorylation | THGFQLKSAYENNLM CCCEECCCHHHCCCC | 44.68 | 29978859 | |
| 470 | Phosphorylation | GFQLKSAYENNLMPY CEECCCHHHCCCCCC | 26.70 | 29978859 | |
| 477 | Phosphorylation | YENNLMPYTNYTFDF HHCCCCCCCCEEECC | 8.14 | 29978859 | |
| 478 | Phosphorylation | ENNLMPYTNYTFDFK HCCCCCCCCEEECCC | 18.84 | 29978859 | |
| 480 | Phosphorylation | NLMPYTNYTFDFKGV CCCCCCCEEECCCCC | 10.86 | 29978859 | |
| 481 | Phosphorylation | LMPYTNYTFDFKGVI CCCCCCEEECCCCCC | 20.85 | 29978859 | |
| 490 | Phosphorylation | DFKGVIDYIFYSKTH CCCCCCEEEEEECCC | 5.04 | - | |
| 493 | Phosphorylation | GVIDYIFYSKTHMNV CCCEEEEEECCCCEE | 10.33 | - | |
| 494 | Phosphorylation | VIDYIFYSKTHMNVL CCEEEEEECCCCEEC | 21.96 | - | |
| 531 | Phosphorylation | HIPSDHFSLLTQLEL CCCCCHHHHHHHHCC | 21.03 | 24719451 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of CNO6L_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CNO6L_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CNO6L_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| ZSCA1_HUMAN | ZSCAN1 | physical | 20211142 | |
| CNOT1_HUMAN | CNOT1 | physical | 17452450 | |
| CNOT2_HUMAN | CNOT2 | physical | 17452450 | |
| CNOT3_HUMAN | CNOT3 | physical | 17452450 | |
| CAF1A_HUMAN | CHAF1A | physical | 17452450 | |
| CNOT9_HUMAN | RQCD1 | physical | 17452450 | |
| TB182_HUMAN | TNKS1BP1 | physical | 17452450 | |
| CNO10_HUMAN | CNOT10 | physical | 17452450 | |
| CAF1B_HUMAN | CHAF1B | physical | 17452450 | |
| TTP_HUMAN | ZFP36 | physical | 21078877 | |
| CNOT6_HUMAN | CNOT6 | physical | 27173435 | |
| CNOT2_HUMAN | CNOT2 | physical | 27173435 | |
| CNOT7_HUMAN | CNOT7 | physical | 27173435 | |
| TB182_HUMAN | TNKS1BP1 | physical | 27173435 | |
| CNO11_HUMAN | CNOT11 | physical | 27173435 | |
| CNO10_HUMAN | CNOT10 | physical | 27173435 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...